Please login to the form below

Not currently logged in
Email:
Password:

PR and Med Ed news in brief

Our weekly round-up of news in brief

PMETB consults on fee increases
The Postgraduate Medical Education Training Board (PMETB) is consulting doctors and stakeholders on possible fee increases. The board said the suggested fee levels would allow it to become an ìeffective and financially independent leader and champion of postgraduate medical educationî. Following a consultation in December last year, additional funding was made available by the four UK Health Departments to graduate increases, reducing the level of fees charged from PMETB's suggested £750 for a CCT (Certificate of Completion of Training) to £500 and £1,250 for an equivalence route application to £950. The latest consultation again proposes the £750 and £1,250 fee levels. ìOnly through raising fees and exploring other streams of income, can we fulfill our statutory duty of maintaining excellence and promoting postgraduate education,î said PMETB chief executive, Paul Streets.

HCA announces new Introduction to PR workshop
The Healthcare Communications Association has launched a new course on achieving results through effective PR and communications.?This introductory course, on October 26 in London, is aimed at personnel either within communications and new to post, or in departments working alongside communications teams such as marketing, medical, regulatory, legal and market access who wish to gain an insight into the role of communications within the marketing mix. Award-winning case studies and practical activities are featured. A few places remain, with discounts available for HCA member companies. For full details go to www.hca-uk.org/events-diary.

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics